India to South Africa: Rifampicin Export Trade Route

The India to South Africa Rifampicin corridor is one of India's established pharmaceutical export routes, with 242 shipments documented worth a combined $25.4M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 56% of all export value, reflecting the consolidated nature of India's rifampicin manufacturing sector.

Across 11 active suppliers, the average shipment value stands at $105.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.

Shipment activity peaks during October–December, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 26.6%, placing it at rank #17 among India's top rifampicin export destinations globally.

On the import side, key buyers of Indian rifampicin in South Africa include NATIONAL DRUG SERVICE ORGANISATION, MACLEODS PHARMACEUTICALS SA , MACLEODS PHARMACEUTICALS SA (PTY) L and 21 others. NATIONAL DRUG SERVICE ORGANISATION is the single largest importer with 1 shipments valued at $10.4M USD.

India's rifampicin exports to South Africa are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 70 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in South Africa benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, MACLEODS PHARMACEUTICALS LTD , MACLEODS PHARMACEUTICALS LIMITED — together account for 85% of total trade value on this route. The average shipment value of $105.0K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as rifampicin 150mg+isoniazid 75mg+pyrazina and medicines. rifampicin 150mg+isoniazid 75 , suggesting that buyers in South Africa tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, NATIONAL DRUG SERVICE ORGANISATION is the largest importer with 1 shipments worth $10.4M USD — representing 41% of all rifampicin imports from India on this route. A total of 24 buyers are active on this corridor.